首页> 美国卫生研究院文献>Micromachines >Internal Structure of Matrix-Type Multilayer Capsules Templated on Porous Vaterite CaCO3 Crystals as Probed by Staining with a Fluorescence Dye
【2h】

Internal Structure of Matrix-Type Multilayer Capsules Templated on Porous Vaterite CaCO3 Crystals as Probed by Staining with a Fluorescence Dye

机译:荧光染料染色在多孔球V石CaCO 3晶体上模板化的基质型多层胶囊的内部结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multilayer capsules templated on decomposable vaterite CaCO3 crystals are widely used as vehicles for drug delivery. The capsule represents typically not a hollow but matrix-like structure due to polymer diffusion into the porous crystals during multilayer deposition. The capsule formation mechanism is not well-studied but its understanding is crucial to tune capsule structure for a proper drug release performance. This study proposes new approach to noninvasively probe and adjust internal capsule structure. Polymer capsules made of poly(styrene-sulfonate) (PSS) and poly(diallyldimethylammonium chloride) (PDAD) have been stained with fluorescence dye rhodamine 6G. Physical-chemical aspects of intermolecular interactions required to validate the approach and adjust capsule structure are addressed. The capsules consist of a defined shell (typically 0.5–2 µm) and an internal matrix of PSS-PDAD complex (typically 10–40% of a total capsule volume). An increase of ionic strength and polymer deposition time leads to the thickening of the capsule shell and formation of a denser internal matrix, respectively. This is explained by effects of a polymer conformation and limitations in polymer diffusion through the crystal pores. We believe that the design of the capsules with desired internal structure will allow achieving effective encapsulation and controlled/programmed release of bioactives for advanced drug delivery applications.
机译:在可分解球ate石CaCO3晶体上模板化的多层胶囊被广泛用作药物输送的载体。由于聚合物在多层沉积过程中扩散到多孔晶体中,因此该胶囊通常不代表中空而是类似基质的结构。胶囊的形成机理尚未得到充分研究,但其理解对于调整胶囊结构以获得适当的药物释放性能至关重要。这项研究提出了一种新的方法来无创探测和调整内部胶囊结构。由聚(苯乙烯磺酸盐)(PSS)和聚(二烯丙基二甲基氯化铵)(PDAD)制成的聚合物胶囊已用荧光染料若丹明6G染色。验证了验证方法和调整胶囊结构所需的分子间相互作用的物理化学方面。胶囊由限定的外壳(通常为0.5–2 µm)和PSS-PDAD复合物的内部基质(通常为总胶囊体积的10–40%)组成。离子强度和聚合物沉积时间的增加分别导致胶囊壳的增厚和致密内部基质的形成。这可以通过聚合物构象的影响和聚合物通过晶体孔扩散的限制来解释。我们相信具有期望的内部结构的胶囊的设计将允许实现用于先进药物递送应用的生物活性物质的有效包封和受控/程序释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号